{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:02:10Z","timestamp":1794610930839,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ophtha.2018.05.029","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T09:52:32Z","timestamp":1530870752000},"page":"113-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":699,"title":["Low-Concentration Atropine for Myopia Progression (LAMP) Study"],"prefix":"10.1016","volume":"126","author":[{"given":"Jason C.","family":"Yam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony K.P.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce J.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon T.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement C.","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Pui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2018.05.029_bib1","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1167\/iovs.03-0169","article-title":"Refractive errors in an elderly Chinese population in Taiwan: the Shihpai Eye Study","volume":"44","author":"Cheng","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.05.029_bib2","first-page":"2486","article-title":"Prevalence and risk factors for refractive errors in adult Chinese in Singapore","volume":"41","author":"Wong","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.05.029_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2007.03.075","article-title":"Refractive errors in an elderly Japanese population: the Tajimi study","volume":"115","author":"Sawada","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.05.029_bib4","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1167\/iovs.09-3455","article-title":"Refractive error and biometry in older Chinese adults: the Liwan eye study","volume":"50","author":"He","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.05.029_bib5","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1167\/iovs.12-10106","article-title":"Prevalence of myopia and its association with body stature and educational level in 19-year-old male conscripts in Seoul, South Korea","volume":"53","author":"Jung","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.05.029_bib6","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1167\/iovs.11-8343","article-title":"High prevalence of myopia and high myopia in 5060 Chinese university students in Shanghai","volume":"53","author":"Sun","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.05.029_bib7","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.05.029_bib8","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/bjophthalmol-2015-307724","article-title":"Global variations and time trends in the prevalence of childhood myopia, a systematic review and quantitative meta-analysis: implications for aetiology and early prevention","volume":"100","author":"Rudnicka","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.05.029_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1475-1313.2005.00298.x","article-title":"Myopia and associated pathological complications","volume":"25","author":"Saw","year":"2005","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.ophtha.2018.05.029_bib10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ophtha.2015.10.031","article-title":"Association between eye shape and myopic traction maculopathy in high myopia","volume":"123","author":"Wakazono","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.05.029_bib11","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0161-6420(99)90416-5","article-title":"The relationship between glaucoma and myopia: the Blue Mountains Eye Study","volume":"106","author":"Mitchell","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.05.029_bib12","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.ophtha.2005.06.028","article-title":"Prevalence of asymptomatic macular holes in highly myopic eyes","volume":"112","author":"Coppe","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.05.029_bib13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/eye.2012.279","article-title":"Prescription of atropine eye drops among children diagnosed with myopia in Taiwan from 2000 to 2007: a nationwide study","volume":"27","author":"Fang","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2018.05.029_bib14","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.05.029_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10384-006-0380-7","article-title":"Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study","volume":"51","author":"Fan","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.05.029_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.05.029_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.05.029_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ajo.2013.09.020","article-title":"Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%","volume":"157","author":"Chia","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.05.029_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/jop.2015.0043","article-title":"Atropine 0.01% eyedrops significantly reduce the progression of childhood myopia","volume":"31","author":"Clark","year":"2015","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2018.05.029_bib20","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.ophtha.2017.05.032","article-title":"Atropine for the prevention of myopia progression in children: a report by the American Academy of Ophthalmology","volume":"124","author":"Pineles","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.05.029_bib21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.05.029_bib22","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/jamaophthalmol.2017.1091","article-title":"Efficacy and adverse effects of atropine in childhood myopia: a meta-analysis","volume":"135","author":"Gong","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.05.029_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/09286580490921296","article-title":"Methods for a population-based study of myopia and other eye conditions in school children: the Sydney Myopia Study","volume":"12","author":"Ojaimi","year":"2005","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ophtha.2018.05.029_bib24","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/bjo.2009.158428","article-title":"Development of a Chinese version of the National Eye Institute Visual Function Questionnaire (CHI-VFQ-25) as a tool to study patients with eye diseases in Hong Kong","volume":"93","author":"Chan","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.05.029_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/jop.2009.0135","article-title":"Prevention of myopia onset with 0.025% atropine in premyopic children","volume":"26","author":"Fang","year":"2010","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2018.05.029_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/jop.2006.22.41","article-title":"Prevention of myopia progression with 0.05% atropine solution","volume":"22","author":"Lee","year":"2006","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2018.05.029_bib27","series-title":"International Strabismological Association (ISA)\/American Association for Pediatric Ophthalmology & Strabismus (AAPOS) Joint Meeting","article-title":"Current Trends to Decrease Myopia Progression Survey: An IPOSC Global Study","author":"Mezer","year":"2018"},{"key":"10.1016\/j.ophtha.2018.05.029_bib28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/jop.2011.0027","article-title":"The long-term results of using low-concentration atropine eye drops for controlling myopia progression in schoolchildren","volume":"27","author":"Wu","year":"2011","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2018.05.029_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.1999.15.85","article-title":"Effects of different concentrations of atropine on controlling myopia in myopic children","volume":"15","author":"Shih","year":"1999","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2018.05.029_bib30","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/OPX.0000000000000037","article-title":"Maximum atropine dose without clinical signs or symptoms","volume":"90","author":"Cooper","year":"2013","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ophtha.2018.05.029_bib31","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1167\/iovs.14-14716","article-title":"Analysis of changes in refraction and biometry of atropine- and placebo-treated eyes","volume":"56","author":"Kumaran","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.05.029_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00006324-199906000-00020","article-title":"Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys","volume":"76","author":"Tigges","year":"1999","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ophtha.2018.05.029_bib33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0014-4835(91)90027-C","article-title":"Muscarinic antagonist effects on experimental chick myopia","volume":"52","author":"Stone","year":"1991","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2018.05.029_bib34","first-page":"475","article-title":"A\u00a0history of studies of visual accommodation in birds","volume":"71","author":"Glasser","year":"1996","journal-title":"Q\u00a0Rev Biol"},{"key":"10.1016\/j.ophtha.2018.05.029_bib35","first-page":"205","article-title":"Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism","volume":"34","author":"McBrien","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2018.05.029_bib36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/02713680600770609","article-title":"The presence of m1 to m5 receptors in human sclera: evidence of the sclera as a potential site of action for muscarinic receptor antagonists","volume":"31","author":"Qu","year":"2006","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2018.05.029_bib37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/APO.0000000000000232","article-title":"Topical atropine in the control of myopia","volume":"5","author":"Tan","year":"2016","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.ophtha.2018.05.029_bib38","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.mehy.2007.07.023","article-title":"Light, literacy and the absence of ultraviolet radiation in the development of myopia","volume":"70","author":"Prepas","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ophtha.2018.05.029_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ebiom.2016.07.021","article-title":"Role of chronic inflammation in myopia progression: clinical evidence and experimental validation","volume":"10","author":"Lin","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ophtha.2018.05.029_bib40","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1177\/1535370216640931","article-title":"Cytotoxicity of atropine to human corneal endothelial cells by inducing mitochondrion-dependent apoptosis","volume":"241","author":"Wen","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.ophtha.2018.05.029_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2415-14-40","article-title":"Overnight orthokeratology is comparable with atropine in controlling myopia","volume":"14","author":"Lin","year":"2014","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.05.029_bib42","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ophtha.2008.10.020","article-title":"Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine","volume":"116","author":"Tong","year":"2009","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642018302859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642018302859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:06:08Z","timestamp":1758981968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642018302859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0161642018302859"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.05.029","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-Concentration Atropine for Myopia Progression (LAMP) Study","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}